Objectives: To explore the atrophy rate of entorhinal cortex (ERC) in AD and normal aging
and assess the value of rate measurement of ERC atrophy for classifying subjects with AD …

Objectives: To determine if atrophy rates were higher for entorhinal cortex (ERC) than for
hippocampus in Alzheimer disease (AD), to determine the relationship between …

Background: MRI measures of the entorhinal cortex and the hippocampus have been used
to predict which nondemented individuals with memory problems will progress to meet …

Background: In Alzheimer's disease, neurodegenerative atrophy progresses from the
entorhinal cortex (ERC) to the hippocampus (HP), limbic system and neocortex. The …

Biomarkers for Alzheimer's disease (AD) based on non-invasive methods are highly
desirable for diagnosis, disease progression, and monitoring therapeutics. We aimed to …

Objective: To test the hypothesis that entorhinal cortex (EC) volume decreases at a slower
rate than the hippocampal (HC) volume in healthy adults, and to examine whether the rate of …

Objective: MRI-based measurements of hippocampal atrophy are a sensitive indicator of the
early pathologic degeneration of the medial temporal lobe in AD. However, AD pathology …

The effects of age, subcortical vascular disease, apolipoprotein E (APOE) ɛ4 allele and
hypertension on entorhinal cortex (ERC) and hippocampal atrophy rates were explored in a …

Background: MRI studies have demonstrated differential rates of atrophy in the entorhinal
cortex and hippocampus during the prodromal phase of Alzheimer disease (AD). The …

Objective: To determine if baseline entorhinal and hippocampal volumes and their rate of
atrophy could predict the risk of incident Alzheimer disease (AD). Methods: The authors …